Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2017	Sep. 30, 2016
ASSETS
Cash and cash equivalents	$ 306.1	$ 316.2
Cash, securities and other assets segregated under federal and other regulations (including $247.6 and $618.8 at fair value at March 31, 2017 and September 30, 2016, respectively)	678.7	1,136.3
Securities purchased under agreements to resell	521.7	609.6
Securities Borrowed	119.6	0.0
Deposits with and receivables from:
Exchange-clearing organizations (including $636.5 and $868.5 at fair value at March 31, 2017 and September 30, 2016, respectively)	1,988.6	1,524.4
Broker-dealers, clearing organizations and counterparties (including $34.7 and $(15.2) at fair value at March 31, 2017 and September 30, 2016, respectively)	177.7	237.0
Receivables from customers, net	251.5	194.5
Notes receivable, net	9.1	18.9
Income taxes receivable	1.4	1.1
Financial instruments owned, at fair value (includes securities pledged as collateral that can be sold or repledged of $324.6 and $47.2 at March 31, 2017 and September 30, 2016, respectively)	1,779.1	1,606.1
Physical commodities inventory, net (including $117.8 and $71.2 at fair value at March 31, 2017 and September 30, 2016, respectively)	172.5	123.8
Deferred income taxes, net	40.4	34.5
Property and equipment, net	33.1	29.4
Goodwill and intangible assets, net	60.5	56.6
Other assets	55.9	61.9
Total assets	6,195.9	5,950.3
Liabilities:
Accounts payable and other accrued liabilities (including $0.9 and $0.8 at fair value at March 31, 2017 and September 30, 2016, respectively)	142.5	161.3
Payables to:
Customers	2,799.5	2,854.2
Broker-dealers, clearing organizations and counterparties (including $9.8 and $3.5 at fair value at March 31, 2017 and September 30, 2016), respectively	182.3	260.1
Lenders under loans	244.7	182.8
Senior unsecured notes	0.0	44.5
Income taxes payable	8.6	7.1
Payables under repurchase agreements	1,458.3	1,167.1
Securities Loaned	148.0	0.0
Financial instruments sold, not yet purchased, at fair value	742.9	839.4
Total liabilities	5,726.8	5,516.5
Commitments and contingencies (Note 11)
Stockholders' Equity:
Preferred stock, $0.01 par value. Authorized 1,000,000 shares; no shares issued or outstanding	0.0	0.0
Common stock, $0.01 par value. Authorized 30,000,000 shares; 20,781,686 issued and 18,659,729 outstanding at March 31, 2017 and 20,557,175 issued and 18,435,218 outstanding at September 30, 2016	0.2	0.2
Common stock in treasury, at cost - 2,121,957 shares at March 31, 2017 and September 30, 2016	(46.3)	(46.3)
Additional paid-in capital	256.8	249.4
Retained earnings	285.1	255.1
Accumulated other comprehensive loss, net	(26.7)	(24.6)
Total stockholders' equity	469.1	433.8
Total liabilities and stockholders' equity	$ 6,195.9	$ 5,950.3

Amount combines the carrying amounts for goodwill and finite- and indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquire, adjusted for any amortization recognized prior to adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets, excluding goodwill, which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements. Finite-lived intangible assets are the aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.

No definition available.